0060SP |
Acetoacetate, Serum/Plasma |
0060U |
Acetoacetate, Urine |
0420B |
Betahydroxybutyric Acid, Blood |
0420FL |
Betahydroxybutyric Acid, Fluid |
0642SP |
Betahydroxybutyric Acid, Serum/Plasma |
0642U |
Betahydroxybutyric Acid, Urine |
0645FL |
Bicarbonate, Fluid |
0645U |
Bicarbonate, Urine |
0938R |
Calcium - Total, RBCs |
0938U |
Calcium - Total, Urine |
0960ME |
Cannabinoids Panel (Qualitative), Meconium |
1300ME |
Cocaine and Metabolites (Qualitative), Meconium |
1333SP |
Copper - Free, Serum/Plasma |
1864ME |
Drugs of Abuse Screen (10 Panel), Meconium |
2480SP |
Ketone Bodies Panel, Serum/Plasma |
2481B |
Ketone Panel, Blood |
2481FL |
Ketone Panel, Fluid |
2481U |
Ketone Panel, Urine |
2760ME |
Methadone and Metabolite (Qualitative), Meconium |
4127ME |
Buprenorphine and Metabolite - Total (Qualitative), Meconium |
6904ME |
Drugs of Abuse Screen (7 Panel), Meconium |
8600ME |
Amphetamines Panel (Qualitative), Meconium |
8620ME |
Barbiturates Panel (Qualitative), Meconium |
8670ME |
Opiates - Total (Conjugated/Unconjugated) (Qualitative), Meconium |
8761ME |
Phencyclidine (Qualitative), Meconium |
9145UC |
Comprehensive Drug Screen, Umbilical Cord Tissue Overview: Detection of in utero exposure to drugs of abuse consistent with maternal use during the second and third trimesters of pregnancy; Newborn (neonatal) toxicology |
9146UC |
Ethyl Glucuronide Screen, Umbilical Cord Tissue |
9329ME |
Benzodiazepines Panel (Qualitative), Meconium |
9351UC |
Basic Drug Screen, Umbilical Cord Tissue Overview: Detection of in utero exposure to drugs of abuse consistent with maternal use during the second and third trimesters of pregnancy; Newborn (neonatal) toxicology |
9352UC |
Expanded Drug Screen, Umbilical Cord Tissue Overview: Detection of in utero exposure to drugs of abuse consistent with maternal use during the second and third trimesters of pregnancy; Newborn (neonatal) toxicology |